Cargando…
Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study
PURPOSE: To assess the pharmacokinetics and safety of pure S-ketamine (esketamine) in Chinese patients undergoing painless gastroscopy and evaluate the potential advantage of esketamine in clinical treatment compared with racemate ketamine hydrochloride injection. PATIENTS AND METHODS: A randomized,...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902860/ https://www.ncbi.nlm.nih.gov/pubmed/31827320 http://dx.doi.org/10.2147/DDDT.S224553 |
_version_ | 1783477747816857600 |
---|---|
author | Wang, Jing Huang, Jie Yang, Shuang Cui, Chang Ye, Ling Wang, Sai-ying Yang, Guo-ping Pei, Qi |
author_facet | Wang, Jing Huang, Jie Yang, Shuang Cui, Chang Ye, Ling Wang, Sai-ying Yang, Guo-ping Pei, Qi |
author_sort | Wang, Jing |
collection | PubMed |
description | PURPOSE: To assess the pharmacokinetics and safety of pure S-ketamine (esketamine) in Chinese patients undergoing painless gastroscopy and evaluate the potential advantage of esketamine in clinical treatment compared with racemate ketamine hydrochloride injection. PATIENTS AND METHODS: A randomized, open-label, parallel-controlled, Phase I study was performed with 32 patients undergoing painless gastroscopy. Patients received a single dose of esketamine (0.5 mg/kg) or racemic ketamine (1 mg/kg, esketamine:R-ketamine=1:1), injected in 10 s. Blood samples were collected for pharmacokinetic analysis. The concentrations of esketamine, R-ketamine, S-norketamine, and R-norketamine were measured with a validated liquid chromatography with tandem mass spectrometry (LC-MS/MS) method. RESULTS: After administering a single dose of esketamine and racemate ketamine, the pharmacokinetics parameters of esketamine and S-norketamine are both similar in treatment groups. The clearance of esketamine in two groups was 18.1±3.2 and 18.4±3.4 mL/min•kg, respectively. However, in the ketamine group, esketamine has a larger clearance than R-ketamine (18.4±3.4 mL/min·kg vs 15.8±3.1 mL/min·kg, P<0.001). Further analysis showed that gender did not affect the pharmacokinetics of esketamine and racemate ketamine. Regarding the safety of esketamine and racemate ketamine, no serious adverse events were observed during treatment, and the incidences of adverse events were 75.0% (esketamine) and 87.5% (racemate ketamine). The main adverse reactions were dizziness, agitation, nausea, vomiting, headache, and fatigue. However, compared with racemic ketamine, esketamine offers a shorter recovery time (9 mins vs. 13 mins, P<0.05) and orientation recovery time (11.5 mins vs. 17 mins, P<0.05) after short anesthesia. CONCLUSION: Esketamine administration as a single dose of 0.5 mg/kg was generally safe and tolerated in patients undergoing painless gastroscopy. In terms of anesthesia, a relatively small dose of esketamine can be used instead of racemate ketamine for routine treatment without consideration of gender differences. |
format | Online Article Text |
id | pubmed-6902860 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-69028602019-12-11 Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study Wang, Jing Huang, Jie Yang, Shuang Cui, Chang Ye, Ling Wang, Sai-ying Yang, Guo-ping Pei, Qi Drug Des Devel Ther Original Research PURPOSE: To assess the pharmacokinetics and safety of pure S-ketamine (esketamine) in Chinese patients undergoing painless gastroscopy and evaluate the potential advantage of esketamine in clinical treatment compared with racemate ketamine hydrochloride injection. PATIENTS AND METHODS: A randomized, open-label, parallel-controlled, Phase I study was performed with 32 patients undergoing painless gastroscopy. Patients received a single dose of esketamine (0.5 mg/kg) or racemic ketamine (1 mg/kg, esketamine:R-ketamine=1:1), injected in 10 s. Blood samples were collected for pharmacokinetic analysis. The concentrations of esketamine, R-ketamine, S-norketamine, and R-norketamine were measured with a validated liquid chromatography with tandem mass spectrometry (LC-MS/MS) method. RESULTS: After administering a single dose of esketamine and racemate ketamine, the pharmacokinetics parameters of esketamine and S-norketamine are both similar in treatment groups. The clearance of esketamine in two groups was 18.1±3.2 and 18.4±3.4 mL/min•kg, respectively. However, in the ketamine group, esketamine has a larger clearance than R-ketamine (18.4±3.4 mL/min·kg vs 15.8±3.1 mL/min·kg, P<0.001). Further analysis showed that gender did not affect the pharmacokinetics of esketamine and racemate ketamine. Regarding the safety of esketamine and racemate ketamine, no serious adverse events were observed during treatment, and the incidences of adverse events were 75.0% (esketamine) and 87.5% (racemate ketamine). The main adverse reactions were dizziness, agitation, nausea, vomiting, headache, and fatigue. However, compared with racemic ketamine, esketamine offers a shorter recovery time (9 mins vs. 13 mins, P<0.05) and orientation recovery time (11.5 mins vs. 17 mins, P<0.05) after short anesthesia. CONCLUSION: Esketamine administration as a single dose of 0.5 mg/kg was generally safe and tolerated in patients undergoing painless gastroscopy. In terms of anesthesia, a relatively small dose of esketamine can be used instead of racemate ketamine for routine treatment without consideration of gender differences. Dove 2019-12-06 /pmc/articles/PMC6902860/ /pubmed/31827320 http://dx.doi.org/10.2147/DDDT.S224553 Text en © 2019 Wang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Wang, Jing Huang, Jie Yang, Shuang Cui, Chang Ye, Ling Wang, Sai-ying Yang, Guo-ping Pei, Qi Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study |
title | Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study |
title_full | Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study |
title_fullStr | Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study |
title_full_unstemmed | Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study |
title_short | Pharmacokinetics and Safety of Esketamine in Chinese Patients Undergoing Painless Gastroscopy in Comparison with Ketamine: A Randomized, Open-Label Clinical Study |
title_sort | pharmacokinetics and safety of esketamine in chinese patients undergoing painless gastroscopy in comparison with ketamine: a randomized, open-label clinical study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902860/ https://www.ncbi.nlm.nih.gov/pubmed/31827320 http://dx.doi.org/10.2147/DDDT.S224553 |
work_keys_str_mv | AT wangjing pharmacokineticsandsafetyofesketamineinchinesepatientsundergoingpainlessgastroscopyincomparisonwithketaminearandomizedopenlabelclinicalstudy AT huangjie pharmacokineticsandsafetyofesketamineinchinesepatientsundergoingpainlessgastroscopyincomparisonwithketaminearandomizedopenlabelclinicalstudy AT yangshuang pharmacokineticsandsafetyofesketamineinchinesepatientsundergoingpainlessgastroscopyincomparisonwithketaminearandomizedopenlabelclinicalstudy AT cuichang pharmacokineticsandsafetyofesketamineinchinesepatientsundergoingpainlessgastroscopyincomparisonwithketaminearandomizedopenlabelclinicalstudy AT yeling pharmacokineticsandsafetyofesketamineinchinesepatientsundergoingpainlessgastroscopyincomparisonwithketaminearandomizedopenlabelclinicalstudy AT wangsaiying pharmacokineticsandsafetyofesketamineinchinesepatientsundergoingpainlessgastroscopyincomparisonwithketaminearandomizedopenlabelclinicalstudy AT yangguoping pharmacokineticsandsafetyofesketamineinchinesepatientsundergoingpainlessgastroscopyincomparisonwithketaminearandomizedopenlabelclinicalstudy AT peiqi pharmacokineticsandsafetyofesketamineinchinesepatientsundergoingpainlessgastroscopyincomparisonwithketaminearandomizedopenlabelclinicalstudy |